Deepcell
PrivateLast Round
Series B
Mar 17, 2022
Total Funding Raised
$98M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Deepcell operates in Healthcare & Life Sciences and is based in Menlo Park, California. Its latest recorded funding round was a Series B round in March 2022.
Deepcell is a biotechnology company that provides an AI-powered single cell classification and isolation technology for clinical research.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery, Computer Vision, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deepcell Comparables
Compare Deepcell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ThinkCyte | 88% | |
| NanoCellect Biomedical | 81% | |
| LevitasBio | 79% |
For institutional investors. Book with your work email.
Deepcell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 17, 2022 | ||||
| Series A | Dec 10, 2020 | ||||
| Seed | Dec 27, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Deepcell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Series B, Seed |
| Horizons Ventures | Series B |
| Stanford University | Series A |
| Catalio Capital Management | Seed |
| Koch Disruptive Technologies | Series B |
| Bow Capital | Series B, Series A |
| Casdin Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 113% MoM, from 2.4K to 5K.
- Jul 20, 2026
Open roles increased from 0 to 30, representing 91% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 10, 2026
In Aug '26, Deepcell, Inc. receives $14.9M in venture funding in a deal led by Casstar, Shun Xi Fund and Cenova Capital.
- is_developingAug 20, 2026
On Aug 20th '26 in California, Deepcell, Inc. announces a collaboration with Gilead Sciences to co-develop an AI foundation model for CHO cell line development on Deepcell's REM-I platform to identify high-quality antibody producer cell lines.
- partners_withAug 20, 2026
On Aug 20th '26 in California, Deepcell, Inc. and Gilead Sciences, Inc. announce a collaboration to co-develop a custom CHO cell morphology foundation model on Deepcell's REM-I platform to help identify high-quality antibody producer cell lines.
For institutional investors. Book with your work email.
Deepcell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Deepcell's valuation, stock price, and market status.
Is Deepcell a public or private company?
Deepcell is a private company.
What is the current stock price of Deepcell?
Deepcell is a private company, so its shares have no public market price. Caplight tracks Deepcell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Deepcell worth (valuation)?
Valuation information for Deepcell is not publicly available.
Can I buy Deepcell stock?
Deepcell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Deepcell's last funding round?
Deepcell's most recent funding round was Series B on March 17, 2022.
Who are the main investors in Deepcell?
Key investors in Deepcell include Andreessen Horowitz, Koch Disruptive Technologies, Bow Capital.
Will Deepcell IPO soon?
No public IPO plans have been announced for Deepcell.
How can I track Deepcell secondary market activity?
Caplight tracks bids, offers, and trades in Deepcell's shares on secondary markets.